Table 2.

WIPO Re:Search engagement delivers significant value to companies, research institutions, and scientists interested in research and product development for diseases of poverty.

Advancing Business and Corporate Social Responsibility Objectives

Repurposing of valuable assets to stimulate R&D for diseases of poverty and improve health Opportunities to contribute to international dialogue and action on key global health issues (e.g., UN Sustainable Development Goals, antimicrobial resistance, IP as a driver of R&D innovation, access to medicines) Strengthening of Access to Medicine Index submissions through inclusion of WIPO Re:Search asset-sharing activities [20] (pp. 228, 244)

Accelerating R&D Programs

Customized R&D partnership development and alliance management services aligned with Members’ priorities and interests Access to technologies and expertise from other Members, saving valuable resources and time New perspectives on R&D for diseases of poverty through partnerships with endemic-country scientists Relationship building with UN agencies, governments, funders, researchers, and companies

Expanding Global Brand Awareness and Visibility

Public demonstration of commitment to sharing valuable IP to advance R&D for diseases of poverty Members and collaborations featured in WIPO Re:Search publications, presentations, and social media

Increasing Scientific Recognition

Peer-reviewed publications describing collaboration outcomes Increased eligibility and competitiveness for research funding

Providing Additional Value for LMIC Organizations and Researchers

Access to cutting-edge R&D resources not available in their home countries Opportunities to develop new skills through meaningful collaborations Career development (e.g., awards, promotions) enabled by publications and presentations on WIPO Re:Search activities